Williamson B R, Lambert M J, Teates C D, Bray S T, Wakefield J A
Clin Nucl Med. 1978 Sep;3(9):343-5. doi: 10.1097/00003072-197809000-00001.
The LeVeen shunt has proved valuable in relieving intractable ascites. It is however subject to failure in about 5--8% of cases. To our knowledge there are only three reports in the literature describing the use of nuclides to assess patency; two using 99mTc-sulfur colloid and one using 99mTc-albumin. The purpose of this paper is to add our experience to the data currently published and stress that late liver visualization may occur with an obstructed shunt.
LeVeen分流术已被证明在缓解顽固性腹水中具有重要价值。然而,约5%-8%的病例会出现分流失败。据我们所知,文献中仅有三篇报道描述了使用核素评估分流管通畅情况;两篇使用99mTc-硫胶体,一篇使用99mTc-白蛋白。本文的目的是将我们的经验补充到目前已发表的数据中,并强调分流管阻塞时可能会出现肝脏延迟显影。